Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser

Status unconfirmed · Phase 1

Conditions studied: Diabetic Macular Edema

In brief

This is an investigator-sponsored trial (IST), an open-label pilot study, assessing the safety and biologic activity of bromfenac in subjects with diffuse DME refractory to laser.

Key facts

Study ID

NCT00491166

Run by

Ophthalmic Consultants of Boston

People needed

10

Starts

2007-06-01

Last updated by the study team

2007-06-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age > 18 years
• Center-involved macular edema secondary to diabetes mellitus

You may not qualify if…

• Study eye with edema amenable to focal laser
• Treatment with laser, intraocular steroids, and anti-VEGF agents within 90 days
• Current eye infections

Where it is running

• Ophthalmic Consultants of Boston — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.